Literature DB >> 19537897

Obesity and kidney cancer risk in men: a meta-analysis (1992-2008).

Grata Ildaphonse1, Preethi Sara George, Aleyamma Mathew.   

Abstract

We conducted a quantitative summary analysis to evaluate the recent evidence of kidney cancer risk according to body mass index (BMI) among men. The studies included in this quantitative review were all cohort and case-control studies, which provided information on kidney cancer risk associated with obesity/overweight, published between 1992 and 2008. The details of studies have been identified through searches on the MEDLINE database. We first estimated the risk associated with a unit increase in BMI (1 kg/m(2)) for individual studies using logit-linear model. After deriving the natural logarithm of the risk per unit of BMI for all studies, we calculated a pooled estimate and corresponding 95% confidence interval (CI) as a weighted average of the risk obtained in individual studies, by giving a weight proportional to its precision. A total of 27 studies (13 cohort studies and 14 case-control studies) that provided kidney cancer risk according to BMI in men were included in the present analysis. The strength of association was almost similar in most of the cohort studies (relative risk (RR) ranged from 1.04-1.06 per unit increase in BMI) and in one study RR was 1.08. There was no heterogeneity across studies (p-value= 0.164). The pooled risk was 1.05 (95% CI= 1.04-1.06) per unit increase in BMI based on the cohort studies. The present analysis confirmed the evidence of kidney cancer risk with increased BMI in men and obesity may be responsible at least in part for the rising incidence rates.

Entities:  

Mesh:

Year:  2009        PMID: 19537897

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Association of hypertension and obesity with renal cell carcinoma risk: a report from the Shanghai Men's and Women's Health Studies.

Authors:  Tian Shen; Xiao-Ou Shu; Yong-Bing Xiang; Hong-Lan Li; Hui Cai; Yu-Tang Gao; Wei Zheng; Loren Lipworth
Journal:  Cancer Causes Control       Date:  2015-06-17       Impact factor: 2.506

2.  Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.

Authors:  Xiang Shu; Jie Lin; Christopher G Wood; Nizar M Tannir; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2013-02-02       Impact factor: 13.506

3.  Renal cell cancer among African Americans: an epidemiologic review.

Authors:  Loren Lipworth; Robert E Tarone; Joseph K McLaughlin
Journal:  BMC Cancer       Date:  2011-04-12       Impact factor: 4.430

4.  Association of body mass index with mortality and postoperative survival in renal cell cancer patients, a meta-analysis.

Authors:  Jiao Zhang; Qiang Chen; Zhan-Ming Li; Xu-Dong Xu; Ai-Fang Song; Li-Shun Wang
Journal:  Oncotarget       Date:  2018-01-12

5.  Obesity, abdominal obesity and subsequent risk of kidney cancer: a cohort study of 23.3 million East Asians.

Authors:  Ga Eun Nam; Kyung Hwan Cho; Kyungdo Han; Chul Min Kim; Byoungduck Han; Sung Jung Cho; Seung Jin Jung; Yeongkeun Kwon; Yang Hyun Kim; Do Hoon Kim; Seon Mee Kim; Youn Seon Choi; Yong Kyun Roh; Yong Gyu Park
Journal:  Br J Cancer       Date:  2019-06-24       Impact factor: 7.640

Review 6.  Associating the risk of three urinary cancers with obesity and overweight: an overview with evidence mapping of systematic reviews.

Authors:  Jiyuan Shi; Liang Zhao; Ya Gao; Mingming Niu; Meili Yan; Yamin Chen; Ziwei Song; Xueni Ma; Peng Wang; Jinhui Tian
Journal:  Syst Rev       Date:  2021-02-17

7.  High body mass index and cancer risk-a Mendelian randomisation study.

Authors:  Marianne Benn; Anne Tybjærg-Hansen; George Davey Smith; Børge Grønne Nordestgaard
Journal:  Eur J Epidemiol       Date:  2016-04-09       Impact factor: 8.082

8.  Metabolic factors associated with risk of renal cell carcinoma.

Authors:  Christel Häggström; Kilian Rapp; Tanja Stocks; Jonas Manjer; Tone Bjørge; Hanno Ulmer; Anders Engeland; Martin Almqvist; Hans Concin; Randi Selmer; Börje Ljungberg; Steinar Tretli; Gabriele Nagel; Göran Hallmans; Håkan Jonsson; Pär Stattin
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.